Authors

Ellie Paige

PhD, Team Head, Cardiovascular Disease Prevention, QIMR Berghofer Medical Research Institute, Brisbane, Qld; Visiting Fellow, National Centre for Epidemiology and Population Health, The Australian National University, Canberra, ACT

Risk treatment thresholds for initiating cardiovascular disease pharmacotherapy: Synthesis of international evidence to support guideline recommendations

Evidence-informed guideline recommendations on risk treatment thresholds for initiating blood pressure- and lipid-lowering therapy for cardiovascular disease primary prevention is presented.